-----

Welcome to the June 2013 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, a mid-year pharmaceutical industry outlook, including the strengths and weaknesses of Big Pharma. A focus on procurement and sourcing with a preview of DCAT’s Sharp Sourcing 2013 conference. Highlights from the 66th World Health Assembly and the pharmaceutical industry’s role in addressing noncommunicable diseases, mental and neurological disorders, R&D for diseases of the developing world, counterfeit medicines, the global vaccine action plan, and neglected tropical diseases.

Global Feature
A Pharma Industry Mid-Year Review and Outlook
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Emerging markets remain strong as established markets fare less well.
>> Read More

Global Feature
Innovation in Sourcing and Procurement
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
The upcoming DCAT Sharp Sourcing 2013 conference addresses the challenges and opportunities in pharmaceutical sourcing and procurement.
>> Read More

Outsourcing
Outsourcing's Modest Role as a Cost-Containment Strategy
Eric Langer,  president of BioPlan Associates
Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.
>> Read More

Pharma Partner Focus
Aesica in an Expansion Mode
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
The CMO Aesica has used a combination of organic growth and acquisitions to build its business and is seeking to expand its geographic footprint.
>> Read More

Pharma Industry’s Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
>> Read More

Pharma Industry’s Global Health and Sustainability Forum
Pharma Industry Participates in Global Health Initiatives
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Highlights from the 66th World Health Assembly and the pharmaceutical industry’s role in addressing noncommunicable diseases, mental and neurological disorders, R&D for diseases of the developing world, counterfeit medicines, the global vaccine action plan, and neglected tropical diseases.
>> Read More

Industry Events

For the full listing of calendar events, see the Calendar of Events page

Pharmaceutical Technology Webcast
Ensuring Global Regulatory Compliance for Product Registrations: Strategies for Risk Reduction and Operational Efficiency
June 11, 2013 at 2:00 to 3:00 PM EST
Learn from industry and regulatory experts on how to create a robust quality management system for complying with country-based and regional-based regulatory requirements for product registration, product changes, and labeling changes. Gain insight into how to use automation for effectively tracking product registration and related correspondence to ensure global regulatory compliance.
Registration information

Pharmaceutical Technology Webcast
Achieving Raw-Material Transparency in the Pharmaceutical/ Biopharmaceutical Supply Chain
June 18, 11:00 AM to 12:00 PM EST
As regulatory demand increases on biopharmaceutical manufacturers to ensure the quality of the raw materials used for the manufacture of drug substances and formulation of finished drug products, these same demands filter back to suppliers. This 60-minute webcast will examine industry practice and use of regulatory guidance (FDA, EU, and ICH) for developing operational control and quality processes for mitigating risk in the pharmaceutical/biopharmaceutical supply chain. Learn from industry experts how to resolve the challenges toward achieving supply-chain transparency and its management as an ongoing concern.
Registration information

Pharmaceutical Technology Webcast
Risk Mitigation in API Manufacturing in Emerging Markets
June 19, 11:00 AM to 12:00 PM EST
Emerging markets are a crucial part of pharmaceutical companies’ growth strategy.  Pharmaceutical manufacturers must align their strategy with partners that can facilitate access to local markets, manage complex supply chains, meet global and national regulatory standards for quality, and secure production of APIs and intermediates for local as well as established markets in North America and Western Europe. This 60-minute webcast will provide insight and case-study analysis on the approaches taken by pharmaceutical companies to build their manufacturing networks in select emerging markets while mitigating risk in supplier selection and qualification to ensure reliable, consistent API supply.
Registration information

DCAT Sharp Sourcing 2013
July 11, 2013
Grand Hyatt Hotel, New York, NY
An educational program in which industry experts will examine the challenges encountered by globalization, recession, re-shoring, downsizing, productivity pressure, supply-chain risks, and new technologies and regulations on pharmaceutical procurement and sourcing activities. Participants will hear from senior procurement executives of a diverse set of companies who will present their ideas on megatrends occurring in the industry and how they are transforming procurement organizations during this rapid evolution.
Registration information